Optimizing stability during the formulation of therapeutic proteins

Monoclonal antibodies and therapeutic proteins for vaccines require extensive stability characterization during their development phase to improve their probability of successful treatment. We will discuss several case studies that demonstrate how the robust intrinsic fluorescence (nanoDSF) and dynamic light scattering (DLS) data obtained from NanoTemper’s Prometheus instruments helped many groups find better formulations and storage buffers to ultimately expedite the lab to clinic pipeline.

Previous Video
Mischievous membrane proteins (and how to tame them)
Mischievous membrane proteins (and how to tame them)

Are you struggling to tame your mischievous membrane proteins? Find out how NanoTemper can help you to char...

Up next
Understanding the nuances of targeted protein degradation
Understanding the nuances of targeted protein degradation

Bifunctional degrader molecules (also known as PROTACs) and molecular glues recruit proteins to E3 ubiquiti...

×

Sign up to receive
the latest NanoTemper news, product updates, event announcements and more

First Name
Last Name
Company Name
Country
State
Province
State
Region
State
Canton
Agree to Subscribe & Privacy Policy*
*I have fully read, understood and agree to the Privacy Policy. I accept the storing and processing of my personal data by NanoTemper as described in the Privacy Policy.

By completing this form, you provide us consent to contact you with educational content, news and information about our products, services and events. You may unsubscribe at any time.
Thank you!
Error - something went wrong!